Namenda XR 28 Day Titration Pack
RxNorm 996633

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 996633 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Namenda XR 28 Day Titration Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Namenda XR 28 Day Titration Pack
AUI:7258932
View
SY
Namenda XR 28 Day Titration Pack
AUI:7258933
View
BPCK
{7 (24 HR memantine hydrochloride 14 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 21 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 28 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 7 mg Extended Release Oral Capsule [Namenda]) } Pack [Namenda 28 Titration Pack]
AUI:12373400
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Namenda XR 28 Day Titration Pack
(Atom ID: 7258932)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Namenda XR 28 Day Titration Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
996633
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7258932
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
996633
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Namenda XR 28 Day Titration Pack
(Atom ID: 7258933)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Namenda XR 28 Day Titration Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
996633
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7258933
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
996633
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCKPrescribable

Brand Name Pack (BPCK):
{7 (24 HR memantine hydrochloride 14 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 21 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 28 mg Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 7 mg Extended Release Oral Capsule [Namenda]) } Pack [Namenda 28 Titration Pack]
(Atom ID: 12373400)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{7 (24 HR memantine hydrochloride 14 MG Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 21 MG Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 28 MG Extended Release Oral Capsule [Namenda]) / 7 (24 HR memantine hydrochloride 7 MG Extended Release Oral Capsule [Namenda]) } Pack [Namenda 28 Titration Pack]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
996633
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12373400
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
996633
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Memantine


Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.
[Learn More]


* Please review the disclaimer below.